Digital Press Briefing on the United States Support for COVID-19 Vaccine Manufacturing and Production in Africa state.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from state.gov Daily Mail and Mail on Sunday newspapers.
Russia's role in the war dominated the addresses of the US president and Japan PM. Predictably, Modi did not comment on Ukraine or Russia in his opening remarks.
IFC announces $713m funding to Aspen to boost Covid-19 vaccine pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
India could have a fourth Covid vaccine by August with Hyderabad-based Biological E’s candidate having completed its phase one and two trials and about to enter stage three, V K Paul, member-health, NITI Aayog, told reporters on Wednesday.
Besides, Covishield and Covaxin, which are available in India, regulator Drugs Controller General of India (DCGI) has also approved Russia’s Sputnik V.
Paul said that the vaccine was being developed with the help of the department of biotechnology and the company has a capacity to make around 70 million doses per month. “It is a significant development. They are old manufacturers of children’s vaccines and have a major capacity,” Paul said, adding that Biological E will be submitting data of phase one and two clinical trials soon.
Quad officials hail vaccine initiative for 2022
Updated:
Updated:
The logistics being worked out
Share Article
AAA
Quad countries plans to provide 1 billion doses of COVID-19 vaccines to Southeast Asian countries by 2022.
| Photo Credit:
RAFIQ MAQBOOL
The logistics being worked out The vaccine initiative announced by the Quad leaders last week was a “path-breaking effort” at a “truly historic” summit, said Minister of State for External Affairs V. Muraleedharan, as officials in the Australia-India-Japan-U.S. coalition also said that details of the plan to provide 1 billion doses of COVID-19 vaccines to Southeast Asian countries by 2022 are being worked out.
“The Quad vaccine collaboration initiative is a pathbreaking effort, envisioning manufacture of U.S. vaccines in India and delivery to countries in the Indo-Pacific region with support of Japan and Australia. It is an example of collective efforts which can be leveraged for global good in these chal